Altimmune (ALT) Interest Coverage Ratio (2010 - 2026)
Altimmune (ALT) reported Interest Coverage Ratio of 22.7 for Q1 2026, up 99.9% year-over-year from 11.36 in Q1 2025, and up 31.18% quarter-over-quarter from 32.98 in Q4 2025.
Altimmune (ALT) Interest Coverage Ratio (2010 - 2026) Analysis & Trends
Altimmune (ALT) has 17 years of Interest Coverage Ratio data on file, last reported at 22.7 in Q1 2026.
- Interest Coverage Ratio for Q1 2026 came in at 22.7, up 99.9% year-over-year; the trailing twelve-month figure through Mar 2026 was 35.86 (up 99.67% YoY), and the FY2025 annual result was 57.76, up 99.5% from the prior year.
- Interest Coverage Ratio grew to 22.7 in Q1 2026 per ALT's latest filing, from 32.98 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 126.2 in Q4 2022 and troughed at 26794.0 in Q1 2024.
- A 5-year average of 8405.47 and a median of 777.24 in 2023 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2023 and 2026: Interest Coverage Ratio slumped 13421.66% in 2023, then jumped 99.9% in 2026.
- A 5-year view of Interest Coverage Ratio shows it stood at 126.2 in 2022, then tumbled by 13421.66% to 16811.5 in 2023, then sank by 47.91% to 24866.0 in 2024, then surged by 99.87% to 32.98 in 2025, then surged by 31.18% to 22.7 in 2026.
- Business Quant data shows ALT's Interest Coverage Ratio at 22.7 in Q1 2026, 32.98 in Q4 2025, and 42.14 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Altimmune | 336.67 Mn | 336.67 Mn | - | -22.70 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22.70 |
| Dec 31, 2025 | -32.98 |
| Sep 30, 2025 | -42.14 |
| Jun 30, 2025 | -86.83 |
| Mar 31, 2025 | -21,815.00 |
| Dec 31, 2024 | -24,866.00 |
| Sep 30, 2024 | -4,127.83 |
| Jun 30, 2024 | -26,745.00 |
| Mar 31, 2024 | -26,794.00 |
| Dec 31, 2023 | -16,811.50 |
| Sep 30, 2023 | -777.24 |
| Jun 30, 2023 | -9,003.50 |
| Mar 31, 2023 | -10,879.50 |
| Dec 31, 2022 | 126.20 |
| Sep 30, 2022 | -386.75 |
| Jun 30, 2022 | -313.77 |
| Mar 31, 2022 | -314.50 |
| Dec 31, 2021 | 386.85 |
| Sep 30, 2021 | -1,006.18 |
| Jun 30, 2021 | -1,130.18 |